Do you have expertise in business development and project management in the Bioscience and Pharmaceutical R&D field? If so, this opportunity as a Business Development & Project Management Director could be the right role for you.

GSK Research and Development (R&D) focus is on the science of the immune system, human genetics and advanced technologies. World Wide Business Development (WWBD) is part of the R&D team and leads global Business Development activities end to end.

As a Business Development (BD) Director you will be a core part our WWBD team responsible for strengthening our immunology and infectious diseases research and development pipeline through external innovation, encompassing all stages of science and drug development. In scope for the role are all deal structures ranging from collaborations, in licensing to whole company acquisitions. The role reports into the Vice President (VP) and Head of BD for Immunology.

Key Responsibilities:

This role will provide YOU the opportunity to lead key activities to progress YOUR career, these responsibilities include some of the following:

• 
  Establish, evolve and execute the immunology and infectious diseases BD strategy for pharma R&D and keeping it fresh in partnership with R&D and Commercial teams.

• 
  Lead R&D and Commercial matrix teams through the entire deal process

  • 
    Identifying & sourcing the most compelling external preclinical and clinical Immunology and infectious disease opportunities

  • 
    Building investment thesis

  • 
    Deal structuring, negotiating, closing deals

  • 
    Leading investment proposal through GSK governance and Board approval process

• 
  Build a strong external network in Immunology including with biopharma, academic and venture capitalists to partner in the most innovative areas of science.

• 
  Develop an expert understanding of the competitive landscape and competitive intelligence to ensure visibility for the organization to emerging opportunities and changes in the environment.

• 
  Lead the review of inbound opportunities to assess their viability and drive to a prioritization decision

• 
  Design deal structures incorporating smart risking taking for GSK and partners and lead negotiations from initial terms to contracting

• 
  Drive forward prioritized deals through technical and commercial due diligence at pace to enable high quality decision making and lead the team to bring forward the investment proposal to GSK governance boards.

• 
  Establish and strengthen relationship with the potential external partner throughout the process

• 
  Coordinate with GSK’s Alliance Management team to manage the relationship post deal signing to ensure value maximization of the relationship.

Why you?

Basic Qualifications:

We are looking for professionals with these required skills to achieve our goals:

• 
  At least 10 years of experience in the pharmaceutical/biotech industry

• 
  BS degree in a related field

• 
  Experience in biotech or pharma R&D stage business development, including opportunity sourcing, deal structuring and negotiations

• 
  Knowledge of all aspects of the R&D process from early discovery through to marketed products, in addition to an understanding and expertise in business development

• 
  Biopharma commercial/market awareness with good understanding of key drivers that underpin commercial assessments and valuations

• 
  Understanding of biopharma deal structures and financial valuation basics

• 
  Previous experience managing matrix teams

• 
  Experience in representing business cases and driving timely and smart decisions across complex internal and external organizations

Preferred Qualifications:

If you have the following characteristics, it would be a plus:

• 
  Advanced scientific degree (Ph.D, PharmD or MD)

• 
  Expertise in Immunology and/or infectious diseases is desirable

• 
  Ability to thrive in a dynamic environment with high level of agility.

• 
  Excellent executive communications skills

Why GSK?

We’re uniting science, technology and talent to make a difference in more people’s lives, and revolutionizing the way we do R&D.

We’re combining the power of genetic and genomic insights into what causes disease, with the speed and scale of artificial intelligence and machine learning (AI/ML) to make better predictions about who a treatment might work for, and why. We believe this powerful combination of data and technology holds the key to fundamentally transforming medical discovery for the better, improving R&D success rates and shaping how even the most challenging diseases, like neurological conditions and cancer, can be both prevented and treated.

Our pipeline currently comprises of more than 60 vaccines and medicines across four core therapeutic areas including infectious diseases, HIV, oncology and immunology as well at pursuing other science-led opportunities outside our core areas. Many have the potential to be first or best-in-class opportunities for patients and since 2017, we’ve delivered 13 major approvals and more than doubled the number of potential new vaccines and medicines in Phase 3 and registration to 23.

In 2021 we delivered four major product approvals: Cabenuva for HIV, Jemperli for endometrial cancer, Xevudy for COVID-19 and Apretude, our new long-acting medicine for HIV prevention.

Find out more:

Our approach to R&D.

#LI-GSK

If you require an accommodation or other assistance to apply for a job at GSK, please contact the GSK Service Centre at 1-877-694-7547 (US Toll Free) or +1 801 567 5155 (outside US).

GSK is an Equal Opportunity Employer and, in the US, we adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, national origin, religion, sex, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class.

At GSK, the health and safety of our employees are of paramount importance. As a science-led healthcare company on a mission to get ahead of disease together, we believe that supporting vaccination against COVID-19 is the single best thing we can do in the US to ensure the health and safety of our employees, complementary workers, workplaces, customers, consumers, communities, and the patients we serve.

GSK has made the decision to require all US employees to be fully vaccinated against COVID-19, where allowed by state or local law and where vaccine supply is readily available. The only exceptions to this requirement are employees who are approved for an accommodation for religious, medical or disability-related reasons.

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements. For more information, please visit GSK’s Transparency Reporting For the Record site.